Skip to main content
XXII
NASDAQ Life Sciences

22nd Century Redeems $2.01M Preferred Stock, Raises $0.46M via Warrant Inducement

Tom Rudovsky · Reported by Wiseek News
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.5
Mkt Cap
$2.299M
52W Low
$0.453
52W High
$257.025
52W Position info
10% above low
Off High info
100% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

XXII is trading near its 52-week low of $0.453 (10% above the low) on light trading volume (0.2× avg).

Summary

22nd Century Group raised $0.46 million through a warrant inducement, using these proceeds to help redeem $2.01 million of Series B Preferred Stock. This capital structure adjustment reduces a significant liability for the company, which has a market capitalization of only $2.29 million. The transaction also involved engaging Dawson James as a placement agent. This event continues a pattern of complex financing activities for the company, which has repeatedly disclosed substantial doubt about its ability to continue as a going concern in recent SEC filings, including its latest 10-Q.

At the time of this announcement, XXII was trading at $0.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $0.45 to $257.03. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Nov 03, 2026, 12:35 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.0565
Real-time Price: $1.62 info
Change: Reverse Stock Split info
Market Cap: $897.899K info
XXII
Nov 03, 2026, 11:40 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.06355
Real-time Price: $1.62 info
Change: Reverse Stock Split info
Market Cap: $897.899K info
XXII
Oct 23, 2026, 6:22 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.1359
Real-time Price: $1.62 info
Change: Reverse Stock Split info
Market Cap: $897.899K info
XXII
Oct 23, 2026, 5:23 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1942
Real-time Price: $1.62 info
Change: Reverse Stock Split info
Market Cap: $897.899K info
XXII
Oct 22, 2026, 10:36 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.3436
Real-time Price: $1.62 info
Change: Reverse Stock Split info
Market Cap: $897.899K info